Yellow fever vaccine-associated viscerotropic disease: current perspectives

References

• MonathTPVasconcelosPFYellow feverJ Clin Virol20156416017325453327
   PubMed Web of Science ®Google Scholar
• QuaresmaJASPagliariCMedeirosDBADuarteMISVasconcelosPFCImmunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow feverRev Med Virol201323530531823873723
   PubMed Web of Science ®Google Scholar
• JentesESPoumerolGGershmanMDInformal WHO Working Group on Geographic Risk for Yellow FeverThe revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow FeverLancet Infect Dis201111862263221798462
   PubMed Web of Science ®Google Scholar
• HillDRMapping the risk of yellow fever infectionCurr Infect Dis Rep201214324625522477086
   PubMed Web of Science ®Google Scholar
• RogersDJWilsonAJHaySIGrahamAJThe global distribution of yellow fever and dengueAdv Parasitol20066218122016647971
   PubMed Web of Science ®Google Scholar
• BeasleyDWMcAuleyAJBenteDAYellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapyAntiviral Res2015115487025545072
   PubMed Web of Science ®Google Scholar
• WHO Emerging and Other Communicable Diseases, 1998District Guidelines for Yellow Fever SurveillanceGenevaWorld Health Organization1998Report No: WHO/EPI/GEN/98.09
   Google Scholar
• BarrettADMonathTPBarbanVNiedrigMTeuwenDE17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday September12, 2005Vaccine200725152758276517368349
   PubMed Web of Science ®Google Scholar
• PugachevKVGuirakhooFOcranSWHigh fidelity of yellow fever virus RNA polymeraseJ Virol20047821032103814694136
   PubMed Web of Science ®Google Scholar
• RaffertyEDuclosPYactayoSSchusterMRisk of yellow-fever vaccine-associated viscerotropic disease among the elderly: a systematic reviewVaccine2013315798580524079979
   PubMed Web of Science ®Google Scholar
• LeeLAFranzelLAtwellJThe estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI AllianceVaccine201331suppl 2B61B7223598494
   PubMed Web of Science ®Google Scholar
• World Health Organization Regional Office for the Western Pacific RegionImmunization Safety Surveillance: Guidelines for Immunization Programme Managers on Surveillance of Adverse Events Following Immunization2nd edManila, PhilippinesWHO Press2013
   Google Scholar
• GershmanMDStaplesJEBentsi-EnchillADViscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety dataVaccine201230335038505822561144
   PubMed Web of Science ®Google Scholar
• WhittemburyARamirezGHernándezHViscerotropic disease following yellow fever vaccination in PeruVaccine200927435974598119679215
   PubMed Web of Science ®Google Scholar
• ThomasREJacksonDA database in ACCESS for assessing vaccne serious eventsVaccine20155916
   Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGThe PRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200966e100009719621072
   PubMed Web of Science ®Google Scholar
• ThomasRELorenzettiDLSpraginsWJacksonDTyler WilliamsonTReporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic reviewCurr Drug Saf20116314515422122389
   PubMedGoogle Scholar
• ThomasRELorenzettiDLSpraginsWJacksonDWilliamsonTActive and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic reviewVaccine201129284544455521549787
   PubMed Web of Science ®Google Scholar
• ThomasRELorenzettiDLSpraginsWJacksonDWilliamsonTThe safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic reviewJ Trop Med Hyg2012862359372
   Web of Science ®Google Scholar
• BiscayartCCarregaMEPSagradiniSYellow fever vaccine- associated adverse events following extensive immunization in ArgentinaVaccine201432111266127224456625
   PubMed Web of Science ®Google Scholar
• DeSilvaMSharmaAStaplesEArndtBShiehW-JShamesJFatal yellow fever vaccine–associated viscerotropic disease – Oregon, September 2014MMWR Morb Mortal Wkly Rep2015641027928125789744
   PubMed Web of Science ®Google Scholar
• LeungWSChanMCChikSHTsangTYFirst case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong KongJ Travel Med2016234taw02027087559
   PubMed Web of Science ®Google Scholar
• IsenmanHBurnsAA case of yellow-fever associated diseaseN Z Med J20121259295
   PubMedGoogle Scholar
• FournierJ-PBernardinGLaffontCVaccination anti amarile compliquée d’une primo infection grave par le virus de l’immunodeficience humaine (VIH 1): à propos d’une observation [Yellow fever vaccination complicated by a serious primary infection with HIV in connection with an observation]Rétrovirus la Revue du Sida198924154156
   Google Scholar
• A Joint Statement of the US Public Health Service, North Carolina State Board of Health, Forsyth County Health Department and Bowman Gray School of MedicineFatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old childJAMA196619866716724380787
   PubMed Web of Science ®Google Scholar
• BaeH-GDomingoCTenorioAImmune response during adverse events after 17D-derived yellow fever vaccination in EuropeJ Infect Dis2008197111577158418419548
   PubMed Web of Science ®Google Scholar
• PulendranBMillerJQuerecTDCase of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTESJ Infect Dis2008198450050718598196
   PubMed Web of Science ®Google Scholar
• MuñozJVilellaADomingoCYellow fever-associated viscerotropic disease in Barcelona, SpainJ Travel Med200815320220518494699
   PubMed Web of Science ®Google Scholar
• StruchinerCJLuzPMDouradoIRisk of fatal adverse events associated with 17DD yellow fever vaccineEpidemiol Infect2004132593994615473158
   PubMed Web of Science ®Google Scholar
• GerasimonGLowryKRare case of fatal yellow fever vaccine-associated viscerotropic diseaseSouth Med J200598665365616004173
   PubMed Web of Science ®Google Scholar
• DouceRWFreireDTelloBVasquezGACase report: a case of yellow fever vaccine-associated viscerotropic disease in EcuadorAm J Trop Med Hyg201082474074220348528
   PubMed Web of Science ®Google Scholar
• KennedyCCMullonJYellow fever vaccine associated viscerotropic disease in a young woman: a rare complication of a common vaccineCrit Care Med20073512 supplA286
   PubMed Web of Science ®Google Scholar
• VasconcelosPFCLunaEJGallerRBrazilian Yellow Fever Vaccine Evaluation GroupSerious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two casesLancet20013589276919711463409
   PubMed Web of Science ®Google Scholar
• de FilippisAMBNogueiraRMRJaborAVIsolation and characterization of wild type yellow fever virus in cases temporally associated with 17 DD vaccination during an outbreak of yellow fever in BrazilVaccine2004229–101073107815003633
   PubMed Web of Science ®Google Scholar
• LevySMullaneKMillerMAdverse events associated with 17D-derived yellow fever vaccination – United States, 2001–2002MMWR Morb Mortal Wkly Rep2002514498999312455906
   PubMedGoogle Scholar
• BelsherJLGayPBrintonMFatal multiorgan failure due to yellow fever vaccine-associated viscerotropic diseaseVaccine200725508480848518023511
   PubMed Web of Science ®Google Scholar
• ChanRCPenneyDJLittleDCarterIWRobertsJARawlinsonWDHepatitis and death following vaccination with 17D-204 yellow fever vaccineLancet2001358927612112211463415
   PubMed Web of Science ®Google Scholar
• MartinMTsaiTFCroppBFever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four casesLancet200135892769810411463410
   PubMed Web of Science ®Google Scholar
• de Mello VieiraJSinariVVasconcelos DiasFVUm caso de hepatite letal após vacinação anti-amarílica [A case of fatal hepatitis due to yellow fever vaccine]J Soc Cienc Med Lisb19651295172 Portuguese14307568
   PubMedGoogle Scholar
• ZhouQAdverse effects of attenuated yellow fever vaccine with multiple organ injury – a case reportZhong Hua Yi Xue Za Zhi20058513936
   PubMedGoogle Scholar
• MonathTPCetronMSTeuwenDEYellow fever vaccinePlotkinSAOrensteinWAOffitPAVaccines5th ed Chap. 36PhiladelphiaSaunders/Elsevier20089591056
   Google Scholar
• MonathTPShort report: suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United StatesAm J Trop Med Hyg201082591992120439976
   PubMed Web of Science ®Google Scholar
• VellozziCMitchellTMillerEYellow Fever Vaccine Safety Working GroupYellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteriod therapy: eleven United States cases, 1996–2004Am J Trop Med Hyg200675233333616896144
   PubMed Web of Science ®Google Scholar
• EngelARVasconcelosPFCMcArthurMABarrettADTCharacterization of a viscerotropic yellow fever variant from a patient in BrazilVaccine2006242803280916464518
   PubMed Web of Science ®Google Scholar
• O’ConghaileSOAlsharbatyMJMcDermottSRConlonPJRoystonMDDwyerRCFulminant hepatitis and multisystem organ failure following yellow fever vaccination: description of a fatal caseAnaesth Intensive Care201442342342424794484
   PubMed Web of Science ®Google Scholar
• KitchenerSViscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAXVaccine20042217–182103210515149765
   PubMed Web of Science ®Google Scholar
• AdhiyamanVOkeACefalCEffects of yellow fever vaccinationLancet200135819071908
   PubMed Web of Science ®Google Scholar
• AppenzellerSFariaAVZanardiVAFernandesSRCostallatLTLCendesFVascular involvement of the central nervous system and systemic diseases: etiologies and MRI findingsRheumatol Int2008281211291137
   Web of Science ®Google Scholar
• RowlandMPlackettTPSmithRYellow fever vaccine-associated viscerotropic diseaseMil Med2012177446746922594140
   PubMed Web of Science ®Google Scholar
• TroilletNLaurencetFLetter to the editorLancet200135819081909
   PubMed Web of Science ®Google Scholar
• TurpoGTiconaMUchuyaJWhittemburyASeligmanSJThird case of fatal yellow fever vaccine-associated viscerotropic disease in a young Peruvian womanAm J Trop Med Hyg2010875 suppl 1383 Conference of the Annual Meeting of the Am Soc Trop Med Hyg, Atlanta, November 2012, Conf Pub 87(5 Suppl 1):383
   Google Scholar
• Van LangenbergERAcute necrosis of the liver. An unusual caseLancet19442436286244245
   Google Scholar
• MartinsRDMMaiaMDLDSantosEMDYellow fever vaccine post-marketing surveillance in BrazilProcedia Vaccinol201022178183
   Google Scholar
• Ministério do Saúde, Brasil. Boletim de Atualização – Dezembro/2009 [webpage on the Internet]Emergências em Saúde Pública de Importância Nacional (ESPIN) de Febre Amarela Silvestre em São Paulo e no Rio Grande do Sul e a Situação Epidemiólogica Atual no Brasil (2008/2009) Available from: http://portal.saude.gov.brAccessed July 8, 2013
   Google Scholar
• Ministério do Saúde, Secretaria de Vigilancia em Saúde, Brasil [webpage on the Internet]Oficina de Trabalho. Subsídios para Discussão e Redefinição da Estratégia de Vacinação Contra Febre Amarela No Brasil200922 Available from: http://portal.saude.gov.brAccessed July 8, 2013
   Google Scholar
• Ministério do Saúde, Fundação Nacional de Saúde, Brasil [webpage on the Internet]Eventos Adversos sérios Associados com a vacina 17D contra Febra Amarela200923 Available from: http://portal.saude.gov.brAccessed July 8, 2013
   Google Scholar
• RomanoAPCostaZGRamosDGYellow fever outbreaks in unvaccinated populations, Brazil, 2008–2009PLoS Negl Trop Dis201483e274024625634
   PubMed Web of Science ®Google Scholar
• LawrenceGMenziesRBurgessMSurveillance of adverse events following immunisation: Australia, 2000–2002Commun Dis Intell2003273307323
   Google Scholar
• LawrenceGLBurgessMAKassRBAge-related risk of adverse events following yellow fever vaccination in AustraliaCommun Dis Intell2004282244248
   PubMedGoogle Scholar
• KhromavaAYEidexRBWeldLHYellow Fever Vaccine Safety Working GroupYellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse eventsVaccine200523253256326315837230
   PubMed Web of Science ®Google Scholar
• LindseyNPSchroederBAMillerERAdverse event reports following yellow fever vaccinationVaccine200826486077608218809449
   PubMed Web of Science ®Google Scholar
• NordinJParkerEDVazquez-BenitezGSafety of the yellow fever vaccine: a retrospective studyJ Travel Med201320636837324118538
   PubMed Web of Science ®Google Scholar
• van de PolEMGisolfEHRichterCA case suspected for yellow fever vaccine-associated viscerotropic disease in the NetherlandsJ Travel Med201421642142424920138
   PubMed Web of Science ®Google Scholar
• WHO [webpage on the Internet]International travel and health Yellow FeverGenevaWorld Health Organization Available from: http://www.who.int/ith/vaccines/yf/en/Accessed May 24, 2016
   Google Scholar
• CDC [webpage on the Internet]ACIP Yellow Fever Vaccine Recommendations Available from: www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/yf.htmlAccessed May 24, 2016
   Google Scholar
• MonathTPCetronMSMcCarthyKYellow fever 17D vaccine safety and immunogenicity in the elderlyHum Vaccine200515207214
   PubMed Web of Science ®Google Scholar
• SchumacherZBourquinCHeiningerUSurveillance for adverse events following immunization (AEFI) in Switzerland–1991–2001Vaccine201028244059406420406662
   PubMed Web of Science ®Google Scholar
• MartinMWeldLHTsaiTFAdvanced age a risk factor for illness temporally associated with yellow fever vaccinationEmerg Infect Dis20017694595111747720
   PubMed Web of Science ®Google Scholar
• ThomasRELorenzettiDLSpraginsWMortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic reviewAm J Pub Health20131033e16e29
   PubMed Web of Science ®Google Scholar
• MonathTPGershmanMStaplesJEBarrettADTYellow fever vaccinePlotkinSAOrensteinWAOffittPAVaccines6th ed Chap. 38EdinburghElsevier/Saunders2013870968
   Google Scholar
• SeligmanSJYellow fever virus vaccine-associated deaths in young womenEmerg Infect Dis201117101891189322000363
   PubMed Web of Science ®Google Scholar
• MiyajiKTLuizAMLaraANActive assessment of adverse events following yellow fever vaccination of persons aged 60 years or moreHum Vaccin Immunother20139227728223291944
   PubMed Web of Science ®Google Scholar